Prurigo nodularis Trials in Saint Joseph, United States
Conditions / Prurigo nodularis / Saint Joseph, United States
Prurigo nodularis has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05061693 | A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis | COMPLETED | PHASE2 |
| NCT03546816 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | COMPLETED | PHASE3 |
| NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | TERMINATED | PHASE3 |
| NCT03497975 | PRISM Study-Pruritus Relief Through Itch Scratch Modulation | COMPLETED | PHASE2/PHASE3 |
| NCT04501679 | A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | COMPLETED | PHASE3 |
| NCT05052983 | A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis | COMPLETED | PHASE3 |
| NCT04204616 | A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06366750 | A Study of Barzolvolimab in Patients With Prurigo Nodularis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06516952 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) | RECRUITING | PHASE3 |
| NCT04501666 | Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) | COMPLETED | PHASE3 |